8-K

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (Date of earliest event reported): October 31, 2007

                              Sono-Tek Corporation
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)

                         Commission File Number: 0-16035

            New York                                  14-1568099
    ------------------------                    ------------------------
    (State of Incorporation)                    (I.R.S. Employer ID No.)


      2012 Route 9W, Milton, New York                        12547
  ----------------------------------------                 ----------
  (Address of Principal Executive Offices)                 (Zip Code)

       Registrant's telephone number, including area code (845) 795-2020
                                                          --------------

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligations of the registrant under any of the following
provisions:

|_|   Written communications pursuant to Rule 425 under Securities Act (17 CFR
      230.425)

|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)

|_|   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))

|_|   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240.13e-4(c))



Item 7.01:  Regulation FD Disclosure.

On October 31, 2007, the Company issued a shareholder letter which included the
quarterly sales revenue, net income and earnings per share for the three month
period ended August 31, 2007 in the form of the attached exhibit 99.1.

Item 9.01   Financial Statements and Exhibits.

(d)     Exhibits

99.1    Shareholder letter.


                                    Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                                     SONO-TEK CORPORATION

                                                     By: /s/ Stephen J. Bagley
                                                         ---------------------
                                                         Stephen J. Bagley
                                                         Chief Financial Officer

November 5, 2007

EX-99.1

                                                                    Exhibit 99.1


              Sono-Tek Announces Major Business Development Program

                              Fall 2007 Newsletter


Dear Shareholder:

Some of you may not have seen the earnings release for the second quarter of our
current fiscal year on the internet, we have included the following excerpts for
all of our shareholders:

Sono-Tek Corporation (OTC BB: SOTK) announced sales of $1,414,523 for the three
months ended August 31, 2007, compared to sales of $1,833,938 for the same
period last year. For the three months ended August 31, 2007, the Company had
net income of $12,070 compared to $233,836 for the prior year period. Earnings
per share for the three months ended August 31, 2007 was $.00 compared to $.02
for the prior year period.

Sales were lower than last year due to a slowdown in the US economy and its
impact on the Company's customers. One factor has been the decline in the
domestic housing market and its impact on electronics purchases. However, sales
were higher than the $1,232,643 reported in the first quarter of the current
fiscal year. Net income for the second quarter was below the same quarter of
last year due to the reduced sales volume noted above, as well as the funding of
new initiatives from operating income in the current quarter.


Business cycles and periodic slowdowns are a part of economic life, and our
business is not immune to their impact. However, our responsibility is to seek
profitable growth in spite of obstacles the economy may place in our path. The
catch is in the words "profitable growth", since in most cases it takes money to
make money. Specifically, the Company has a choice when things are slow to
either show current profits by cost cutting, or to move forward on technical and
market development at the expense of current profits.

We have been following the latter path of investing in future growth for the
past two quarters, and in fact will be doing more of this going forward, as you
can see from the second part of the press release:

                   New Business Development Program Announced
Dr. Christopher L. Coccio, Chairman and CEO, announced that "a recent meeting of
the Board of Directors has approved a multi-year business development program
where the Company will invest approximately $2M in creating new business growth.
The program will be led by Dr. Joseph Riemer, who was recently appointed as
President of Sono-Tek, and has as its goal a substantial increase in revenues
over the next several years to move Sono-Tek into the $10-$20m revenue arena.
Funding for the program will be primarily derived from operating revenues,
possibly augmented with some of our cash reserves, and is not expected to
require external funding. The program is similar to the new initiatives that
have been underway in the first and second quarters of the current fiscal year."



The program will focus on areas where we have demonstrated new capabilities and
on areas where there appears to be more opportunity that we could serve with
additional technical and sales personnel.

Such areas include medical device coatings, coatings for solar and fuel cells
serving the clean energy market, biodegradable food packaging and applications
of natural antimicrobials to food products, and the glass and textile
industries. In our estimate, our future sales for the food industry alone could
become Sono-Tek's largest business segment over time.

Sono-Tek is pursuing this program as a means to grow both the top and bottom
lines. Sono-Tek believes that trading current income for future growth is the
right choice for the Company at this time, and it will closely monitor the
plans' execution and progress.


We are excited about where this program can take us. We have put in place
organizational changes designed to focus on the growth opportunities before us,
and we are bringing in additional talent to strengthen our structure.
Specifically, we are creating several Strategic Business Units, each headed by a
director who will be responsible for the growth in their segment. Each of the
areas we will be pursuing has specific targets and resources, and in most cases,
demonstrated success of our equipment in the application. We intend to apply our
marketing, sales and technical resources to ramp up these promising applications
and through them, generate larger streams of revenue and income.

We believe this is the right choice for Sono-Tek at this time, considering the
success we have had in expanding into the medical device field and the
international market in previous years. It is our hope and expectation that we
will be a stronger, more diverse, and profitable Company after one to two years
of this program.

Sincerely,


Christopher L. Coccio, PhD
Chairman and CEO


      This earnings release contains forward looking statements regarding future
      events and the future performance of Sono-Tek Corporation that involve
      risks and uncertainties that could cause actual results to differ
      materially. These factors include, among other considerations, general
      economic and business conditions; political, regulatory, competitive and
      technological developments affecting the Company's operations or the
      demand for its products; timely development and market acceptance of new
      products; adequacy of financing; capacity additions, the ability to
      enforce patents and the successful implementation of the business
      development program. We refer you to documents that the company files with
      the Securities and Exchange Commission, which includes Form 10-KSB and
      Form 10-QSBs containing additional important information.